Seelos Therapeutics Inc (SEEL)
0.2803
-0.01
(-3.68%)
USD |
NASDAQ |
Apr 29, 16:00
0.3025
+0.02
(+7.92%)
After-Hours: 20:00
Seelos Therapeutics Revenue (Quarterly)
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2023 | 0.808M |
| December 31, 2022 | |
| September 30, 2022 | |
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | |
| September 30, 2021 | |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | |
| September 30, 2020 | |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | |
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | |
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 |
| Date | Value |
|---|---|
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | 2.629M |
| September 30, 2015 | 1.273M |
| June 30, 2015 | 0.462M |
| March 31, 2015 | 0.475M |
| December 31, 2014 | 1.907M |
| September 30, 2014 | 1.898M |
| June 30, 2014 | 5.454M |
| March 31, 2014 | |
| December 31, 2013 | 0.362M |
| September 30, 2013 | 0.028M |
| June 30, 2013 | 1.192M |
| March 31, 2013 | 0.929M |
| December 31, 2012 | 2.377M |
| September 30, 2012 | 4.895M |
| June 30, 2012 | 0.003M |
| March 31, 2012 | 0.781M |
| December 31, 2011 | -0.8616M |
| September 30, 2011 | 0.7994M |
| June 30, 2011 | 1.595M |
| March 31, 2011 | 1.587M |
| December 31, 2010 | 1.035M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
0.808M
Minimum
Mar 2023
0.808M
Maximum
Mar 2023
0.808M
Average
0.808M
Median
Mar 2023
Revenue (Quarterly) Benchmarks
| 180 Life Sciences Corp | -- |
| Acurx Pharmaceuticals Inc | -- |
| NovaBay Pharmaceuticals Inc | 3.727M |
| Palatin Technologies Inc | 2.034M |
| iBio Inc | -- |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -5.453M |
| Total Expenses (Quarterly) | 8.011M |
| EPS Diluted (Quarterly) | 0.07 |
| Enterprise Value | 15.05M |
| Earnings Yield | -4.90K% |
| Normalized Earnings Yield | -6751.04 |